Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases.

Park CG, Hartl CA, Schmid D, Carmona EM, Kim HJ, Goldberg MS.

Sci Transl Med. 2018 Mar 21;10(433). pii: eaar1916. doi: 10.1126/scitranslmed.aar1916.

PMID:
29563317
2.

T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity.

Schmid D, Park CG, Hartl CA, Subedi N, Cartwright AN, Puerto RB, Zheng Y, Maiarana J, Freeman GJ, Wucherpfennig KW, Irvine DJ, Goldberg MS.

Nat Commun. 2017 Nov 23;8(1):1747. doi: 10.1038/s41467-017-01830-8.

3.

A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis.

Wagenblast E, Soto M, Gutiérrez-Ángel S, Hartl CA, Gable AL, Maceli AR, Erard N, Williams AM, Kim SY, Dickopf S, Harrell JC, Smith AD, Perou CM, Wilkinson JE, Hannon GJ, Knott SR.

Nature. 2015 Apr 16;520(7547):358-62. doi: 10.1038/nature14403. Epub 2015 Apr 8.

Supplemental Content

Loading ...
Support Center